Cerity Partners LLC Purchases 23,458 Shares of Tenet Healthcare Corporation $THC

Cerity Partners LLC lifted its position in shares of Tenet Healthcare Corporation (NYSE:THC) by 19.4% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 144,081 shares of the company’s stock after acquiring an additional 23,458 shares during the period. Cerity Partners LLC owned approximately 0.16% of Tenet Healthcare worth $29,254,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in THC. Chung Wu Investment Group LLC purchased a new position in shares of Tenet Healthcare in the second quarter worth $35,000. Canada Pension Plan Investment Board purchased a new position in Tenet Healthcare in the 2nd quarter worth about $35,000. Trust Co. of Vermont purchased a new stake in shares of Tenet Healthcare during the 3rd quarter valued at about $41,000. Caitong International Asset Management Co. Ltd grew its stake in shares of Tenet Healthcare by 2,227.3% in the second quarter. Caitong International Asset Management Co. Ltd now owns 256 shares of the company’s stock worth $45,000 after acquiring an additional 245 shares during the period. Finally, True Wealth Design LLC lifted its position in Tenet Healthcare by 238.2% during the second quarter. True Wealth Design LLC now owns 257 shares of the company’s stock valued at $45,000 after purchasing an additional 181 shares during the period. 95.44% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Tenet Healthcare

In other news, Director Richard W. Fisher sold 2,500 shares of the firm’s stock in a transaction dated Wednesday, October 29th. The stock was sold at an average price of $208.43, for a total transaction of $521,075.00. Following the completion of the transaction, the director owned 8,792 shares in the company, valued at $1,832,516.56. This trade represents a 22.14% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Nadja West sold 2,178 shares of the business’s stock in a transaction dated Monday, December 15th. The stock was sold at an average price of $197.47, for a total value of $430,089.66. Following the completion of the sale, the director owned 28,480 shares in the company, valued at $5,623,945.60. This represents a 7.10% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 45,500 shares of company stock worth $9,247,071. 0.81% of the stock is currently owned by company insiders.

Tenet Healthcare Stock Up 0.5%

NYSE THC opened at $203.00 on Friday. The company has a current ratio of 1.71, a quick ratio of 1.64 and a debt-to-equity ratio of 2.27. Tenet Healthcare Corporation has a 12 month low of $109.82 and a 12 month high of $222.82. The stock’s 50 day moving average is $202.33 and its 200 day moving average is $189.59. The stock has a market cap of $17.84 billion, a PE ratio of 13.91, a P/E/G ratio of 0.86 and a beta of 1.41.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings data on Tuesday, October 28th. The company reported $3.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.33 by $0.37. The firm had revenue of $5.29 billion for the quarter, compared to analysts’ expectations of $5.26 billion. Tenet Healthcare had a net margin of 6.49% and a return on equity of 25.11%. The company’s revenue for the quarter was up 3.2% compared to the same quarter last year. During the same quarter last year, the business posted $2.93 earnings per share. Tenet Healthcare has set its FY 2025 guidance at 15.930-16.26 EPS. Research analysts predict that Tenet Healthcare Corporation will post 12.24 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts have weighed in on THC shares. Weiss Ratings upgraded shares of Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Monday, December 29th. Mizuho boosted their price target on Tenet Healthcare from $194.00 to $225.00 and gave the company an “outperform” rating in a research note on Friday, October 17th. Raymond James Financial set a $245.00 price objective on shares of Tenet Healthcare in a report on Wednesday, October 29th. Truist Financial reaffirmed a “buy” rating and set a $240.00 target price (up from $225.00) on shares of Tenet Healthcare in a report on Monday, November 3rd. Finally, Cowen reiterated a “buy” rating on shares of Tenet Healthcare in a research note on Wednesday. One analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $233.81.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.